<?xml version="1.0" encoding="UTF-8"?>
<ref id="B8">
 <label>8</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Yang</surname>
    <given-names>Y</given-names>
   </name>
   <name>
    <surname>Wang</surname>
    <given-names>Z</given-names>
   </name>
   <name>
    <surname>Fang</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Yu</surname>
    <given-names>Q</given-names>
   </name>
   <name>
    <surname>Han</surname>
    <given-names>B</given-names>
   </name>
   <name>
    <surname>Cang</surname>
    <given-names>S</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Efficacy and Safety of Sintilimab Plus Pemetrexed and Platinum as First-Line Treatment for Locally Advanced or Metastatic Nonsquamous NSCLC: A Randomized, Double-Blind, Phase 3 Study (Oncology pRogram by InnovENT Anti-PD-1-11)</article-title>. 
  <source>J Thorac Oncol</source> (
  <year>2020</year>) 
  <volume>15</volume>:
  <page-range>1636–46</page-range>. 
  <pub-id pub-id-type="doi">10.1016/j.jtho.2020.09.028</pub-id>
 </mixed-citation>
</ref>
